Pictet Asset Management
RCUS icon

Pictet Asset Management’s Arcus Biosciences RCUS Stock Holding History

Pictet Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Hold
11,462
– – ﹤0.01% 1699
2026
Q1 		$248K Hold
11,462
– – ﹤0.01% 1824
2025
Q4 		$273K Buy
+11,462
New +$234K ﹤0.01% 1758
2025
Q2 		– Sell
-10,452
Closed -$82K – 2046
2025
Q1 		$82K Buy
+10,452
New +$121K ﹤0.01% 1959
2024
Q1 		– Sell
-355,143
Closed -$6.78M – 2017
2023
Q4 		$6.78M Buy
355,143
+9,549
+3% +$153K 0.01% 736
2023
Q3 		$6.2M Buy
+345,594
New +$6.94M 0.01% 727

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Pictet Asset Management's RCUS Position: Q2 2026 in Review

Pictet Asset Management held its Arcus Biosciences (RCUS) position steady in Q2 2026 at 11,462 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #1699.

Pictet Asset Management first reported a position in RCUS in Q3 2023 and has held it in 6 quarters since. The position peaked at $6.78M in Q4 2023. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Pictet Asset Management held 11,462 shares of Arcus Biosciences worth $353K as of Q2 2026.
  • Pictet Asset Management left its Arcus Biosciences share count unchanged in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1699 holding.
  • Pictet Asset Management first reported a position in Arcus Biosciences in Q3 2023 and has held it in 6 quarters since.
  • Pictet Asset Management's Arcus Biosciences position peaked at $6.78M in Q4 2023.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.